Status | Study |
Completed |
Study Name: Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Lymphoma Date: 2012-01-26 Interventions: Genetic: gene expression analysis Other: l |
Terminated |
Study Name: A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Condition: Acute Lymphoblastic Leukemia Precursor B-Cell Lymphoblastic Leukemia Date: 2011-11-29 Interventions: Drug: Decitabine 10 mg/m2/day |
Active, not recruiting |
Study Name: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condition: Lymphoblastic Leukemia, Acute T-cell Precursor T-Cell Lymphoblastic Ly Date: 2011-04-22 Interventions: Drug: BMS-906024 Other Name: N |
Completed |
Study Name: Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Date: 2011-02-11 Interventions: Genetic: gene expression analysis Genetic: |
Terminated |
Study Name: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Condition: Relapsed T-Cell Acute Lymphoblastic Leukemia Relapsed T-Cell Ly Date: 2009-09-09 Interventions: Drug: Nelarabine Dose will be |
Completed |
Study Name: DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia Condition: Leukemia Date: 2009-05-09 Interventions: Genetic: microarray analysis Genetic: muta |
Completed |
Study Name: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) Condition: T-ALL, T-NHL (Lymphoblastic) Date: 2008-05-16 Interventions: Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5 |
Recruiting |
Study Name: Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma Condition: Leukemia Lymphoblastic Lymphoma Leukemia, Lymphoblastic, A Date: 2007-07-12 Interventions: Drug: Doxorubicin |
Terminated |
Study Name: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Condition: Leukemia Lymphoma Date: 2007-01-05 Interventions: Drug: Forodesine Hydrochloride Sterile Solution, 5 mg/mL |
Terminated |
Study Name: TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients Condition: Chronic Myelogenous Leukemia Date: 2006-12-22 Interventions: Drug: Imatinib Mesylate (IM) I |